139 related articles for article (PubMed ID: 11182280)
1. Visual-evoked potentials in the assessment of optic gliomas.
Ng YT; North KN
Pediatr Neurol; 2001 Jan; 24(1):44-8. PubMed ID: 11182280
[TBL] [Abstract][Full Text] [Related]
2. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials.
North K; Cochineas C; Tang E; Fagan E
Pediatr Neurol; 1994 Mar; 10(2):117-23. PubMed ID: 8024659
[TBL] [Abstract][Full Text] [Related]
3. Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I.
Vagge A; Camicione P; Pellegrini M; Gatti G; Capris P; Severino M; Di Maita M; Panarello S; Traverso CE
Eur J Ophthalmol; 2021 Mar; 31(2):698-703. PubMed ID: 32066268
[TBL] [Abstract][Full Text] [Related]
4. Central and peripheral steady-state visual evoked potentials in children with optic pathway gliomas.
Rassi SZ; Ospina LH; Bochereau A; Samson Y; Perreault S; Saint-Amour D
Doc Ophthalmol; 2019 Oct; 139(2):137-149. PubMed ID: 31243619
[TBL] [Abstract][Full Text] [Related]
5. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
Wolsey DH; Larson SA; Creel D; Hoffman R
J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
[TBL] [Abstract][Full Text] [Related]
6. Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.
Van Mierlo C; Spileers W; Legius E; Casteels I; Cassiman C
Doc Ophthalmol; 2013 Dec; 127(3):177-90. PubMed ID: 23884797
[TBL] [Abstract][Full Text] [Related]
7. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
8. Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology.
Falsini B; Chiaretti A; Barone G; Piccardi M; Pierri F; Colosimo C; Lazzareschi I; Ruggiero A; Parisi V; Fadda A; Balestrazzi E; Riccardi R
Neurorehabil Neural Repair; 2011; 25(6):512-20. PubMed ID: 21444653
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography in the diagnosis of optic pathway gliomas.
Parrozzani R; Clementi M; Kotsafti O; Miglionico G; Trevisson E; Orlando G; Pilotto E; Midena E
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8112-8. PubMed ID: 24169000
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas.
Kelly JP; Weiss AH
J AAPOS; 2006 Aug; 10(4):298-306. PubMed ID: 16935227
[TBL] [Abstract][Full Text] [Related]
11. Optic Pathway Gliomas in Neurofibromatosis Type 1: Imaging and Monitoring.
Beres SJ
Int Ophthalmol Clin; 2018; 58(4):97-112. PubMed ID: 30239366
[No Abstract] [Full Text] [Related]
12. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings.
Falsini B; Ziccardi L; Lazzareschi I; Ruggiero A; Placentino L; Dickmann A; Liotti L; Piccardi M; Balestrazzi E; Colosimo C; Di Rocco C; Riccardi R
J Neurooncol; 2008 May; 88(1):87-96. PubMed ID: 18246407
[TBL] [Abstract][Full Text] [Related]
14. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG
Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406
[TBL] [Abstract][Full Text] [Related]
15. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas.
Trisciuzzi MT; Riccardi R; Piccardi M; Iarossi G; Buzzonetti L; Dickmann A; Colosimo C; Ruggiero A; Di Rocco C; Falsini B
Clin Neurophysiol; 2004 Jan; 115(1):217-26. PubMed ID: 14706491
[TBL] [Abstract][Full Text] [Related]
16. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
[TBL] [Abstract][Full Text] [Related]
17. Early diagnosis of optic glioma in children with neurofibromatosis type 1.
Rossi LN; Pastorino G; Scotti G; Gazocchi M; Maninetti MM; Zanolini C; Chiodi A
Childs Nerv Syst; 1994 Sep; 10(7):426-9. PubMed ID: 7842431
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
19. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
[TBL] [Abstract][Full Text] [Related]
20. Optic pathway gliomas in children with and without neurofibromatosis 1.
Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA
J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
